Table 3 Quality of life scores in patients randomised to fluticasone or placebo.
Fluticasone | Placebo | |||
|---|---|---|---|---|
Mean difference at 12 months | Mean difference at 12 months | Effect size % partial eta2 | Significance between groups | |
SGRQ total score | -0.98 | -1.43 | < 0.1% | P = 0.83 |
EQ5D total score | -0.03 | 0.03 | 0.2% | P = 0.66 |
EQ5D VAS | -2.16 | -0.29 | < 0.1% | P = 0.97 |